Abstract
Hereditary breast and ovarian cancer syndrome (HBOC) is an inherited condition associated with mutations in the BRCA1 or BRCA2 (BRCA) genes. Identification of individuals with HBOC requires that primary care providers understand the genetic principles required to appropriately collect family history and refer individuals for genetic evaluation. A survey was developed and administered to primary care providers in Georgia to assess their existing knowledge of HBOC and direct targeted educational efforts.
We found that Georgia providers demonstrate some knowledge of basic genetic principles but were unable to consistently identify individuals at risk for HBOC. Knowledge deficits included lack of understanding of inheritance patterns and failure to recognize the significance of ovarian cancer history. Strategies for improving identification of patients with HBOC include increasing provider knowledge and integrating HBOC risk assessment tools into practice. Identification of individuals at risk is the critical first step in the process of reducing incidence of breast and ovarian cancer associated with BRCA mutations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bellcross CA et al (2011) Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med 40:61–66
Brannon Traxler L et al (2014) Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative. Ann Surg Oncol 21:3342–3347
Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30
Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324
Rubinstein W (2001) The genetics of breast cancer. Blackwell Science, Malden
Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333
Howlader N, Noone A, Krapcho M (2013) SEER cancer statistics review, 1975–2010
Weissman SM, Weiss SM, Newlin AC (2012) Genetic testing by cancer site: ovary. Cancer J Sudbury Mass 18:320–327
Kuhl CK et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476
Domchek SM et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967–975
Hartmann LC et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633–1637
Meijers-Heijboer H et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159–164
Rebbeck TR et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055–1062
Eisen A et al (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 23:7491–7496
Finch APM et al (2014) Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol 32:1547–1553
Moyer VA, US Preventive Services Task Force (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160:271–281
Daly MB et al (2014) Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Cancer Netw 12:1326–1338
American College of Obstetricians and Gynecologists, ACOG Committee on Practice Bulletins--Gynecology, ACOG Committee on Genetics & Society of Gynecologic Oncologists (2009) ACOG practice bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol 113:957–966
Robson ME et al (2010) American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28:893–901
Lancaster JM et al (2007) Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107:159–162
Berliner JL, Fay AM, Cummings SA, Burnett B, Tillmanns T (2013) NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. J Genet Couns 22:155–163
Trivers KF et al (2011) Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer 117:5334–5343
Cohn J et al (2014) Physician risk assessment knowledge regarding BRCA genetics testing. J Cancer Educ 30:573--579
Ready KJ et al (2010) Obstetrics/gynecology residents’ knowledge of hereditary breast and ovarian cancer and Lynch syndrome. J Cancer Educ 25:401–404
Acknowledgments
Centers for Disease Control & Prevention Grant: 1U58DP003794-01.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nair, N., Bellcross, C., Haddad, L. et al. Georgia Primary Care Providers’ Knowledge of Hereditary Breast and Ovarian Cancer Syndrome. J Canc Educ 32, 119–124 (2017). https://doi.org/10.1007/s13187-015-0950-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-015-0950-9